146 related articles for article (PubMed ID: 6398313)
1. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
[TBL] [Abstract][Full Text] [Related]
2. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
[TBL] [Abstract][Full Text] [Related]
3. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
[TBL] [Abstract][Full Text] [Related]
4. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
[TBL] [Abstract][Full Text] [Related]
5. [Telethermographic evaluation of the intra-articular administration of thymopentin in rheumatoid arthritis of the knee].
Pappalardo A; Sallì L; Campisi D; Scalici G; Di Marco C; Martorana U
Clin Ter; 1989 Mar; 128(5):321-7. PubMed ID: 2524320
[TBL] [Abstract][Full Text] [Related]
6. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Franchimont P; Hauwaert C; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
[TBL] [Abstract][Full Text] [Related]
7. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296
[TBL] [Abstract][Full Text] [Related]
8. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
[TBL] [Abstract][Full Text] [Related]
9. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised study.
Malaise MG; Hauwaert C; Franchimont P; Danneskiold-Samsoe B; Bach-Andersen R; Gross D; Gerber H; Gerschpacher H; Stocker H; Bolla K
Lancet; 1985 Apr; 1(8433):832-6. PubMed ID: 2858708
[TBL] [Abstract][Full Text] [Related]
10. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
[TBL] [Abstract][Full Text] [Related]
11. [Thymopentin in the treatment of recurrent condylomata acuminata].
Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results on clinical and immunological effects of thymopentin in AIDS.
Clumeck N; van de Perre P; Mascart-Lemone F; Cran S; Bolla K; Duchateau J
Int J Clin Pharmacol Res; 1984; 4(6):459-63. PubMed ID: 6398315
[TBL] [Abstract][Full Text] [Related]
13. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation with thymopentin in humans.
Bolla K; Duchateau J; Delespesse G; Servais G
Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312
[TBL] [Abstract][Full Text] [Related]
15. Thymopentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies.
Grob PJ; Binswanger U; Blumberg A; Gloor HJ; Hany A; Herwig W; Iselin H; Zàruba K; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():107-15. PubMed ID: 3898281
[TBL] [Abstract][Full Text] [Related]
16. [A case of juvenile rheumatoid arthritis treated with thymopentin].
Tucciarone L; Felici W; Greco L; Mechelli A
Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
[TBL] [Abstract][Full Text] [Related]
17. Thymopentin treatment in genital warts of long duration.
Fransen L; Anthoons J; Hoogewijs G; Bolla K
Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
[TBL] [Abstract][Full Text] [Related]
18. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.
Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J
Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of thymopentin in severely burned patients.
Waymack JP; Jenkins M; Warden GD; Solomkin J; Law E; Hummel R; Miller A; Alexander JW
Surg Gynecol Obstet; 1987 May; 164(5):423-30. PubMed ID: 3554564
[TBL] [Abstract][Full Text] [Related]
20. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
